Classification of disease recurrence using transition likelihoods with expectation‐maximization algorithm

When an infectious disease recurs, it may be due to treatment failure or a new infection. Being able to distinguish and classify these two different outcomes is critical in effective disease control. A multi‐state model based on Markov processes is a typical approach to estimating the transition pro...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Statistics in medicine Ročník 41; číslo 23; s. 4697 - 4715
Hlavní autori: Jiang, Huijun, Li, Quefeng, Lin, Jessica T., Lin, Feng‐Chang
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Hoboken, USA John Wiley & Sons, Inc 15.10.2022
Wiley Subscription Services, Inc
Predmet:
ISSN:0277-6715, 1097-0258, 1097-0258
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:When an infectious disease recurs, it may be due to treatment failure or a new infection. Being able to distinguish and classify these two different outcomes is critical in effective disease control. A multi‐state model based on Markov processes is a typical approach to estimating the transition probability between the disease states. However, it can perform poorly when the disease state is unknown. This article aims to demonstrate that the transition likelihoods of baseline covariates can distinguish one cause from another with high accuracy in infectious diseases such as malaria. A more general model for disease progression can be constructed to allow for additional disease outcomes. We start from a multinomial logit model to estimate the disease transition probabilities and then utilize the baseline covariate's transition information to provide a more accurate classification result. We apply the expectation‐maximization (EM) algorithm to estimate unknown parameters, including the marginal probabilities of disease outcomes. A simulation study comparing our classifier to the existing two‐stage method shows that our classifier has better accuracy, especially when the sample size is small. The proposed method is applied to determining relapse vs reinfection outcomes in two Plasmodium vivax treatment studies from Cambodia that used different genotyping approaches to demonstrate its practical use.
Bibliografia:Funding information
National Center for Advancing Translational Sciences, Grant/Award Number: UL1TR002489; National Institute of Allergy and Infectious Diseases, Grant/Award Number: K08AI110651; National Institute on Aging, Grant/Award Number: R01AG073259
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0277-6715
1097-0258
1097-0258
DOI:10.1002/sim.9534